What Is Dengue Fever?

Dengue fever is a mosquito-borne viral illness caused by any of four closely related serotypes of the dengue virus, DENV-1 through DENV-4, which are flaviviruses transmitted to humans mainly through the bite of infected female Aedes aegypti mosquitoes. The disease is endemic across tropical and subtropical Asia, the Americas, Africa, and the Pacific. According to the World Health Organization's dengue fact sheet, roughly half the world's population now lives where transmission is possible, and 2024 produced more reported cases than any previous year on record, with over 14.6 million cases and more than 12,000 deaths.

Dengue is studied primarily as a problem in virology, entomology, and epidemiology, and control of it rests mainly on clinical case management and public health measures. Engineering supports several parts of that effort, supplying rapid diagnostic instrumentation, satellite-based habitat mapping, statistical outbreak forecasting, and the design of large-scale vector control interventions.

Virology and Transmission

Each of the four serotypes produces lasting immunity to itself but only brief cross-protection against the others. A second infection with a different serotype carries a substantially higher risk of severe disease, an effect commonly attributed to antibody-dependent enhancement, in which non-neutralizing antibodies from the first infection help the second virus enter host cells. The clinical and virological picture is summarized in the StatPearls dengue fever review hosted by the National Center for Biotechnology Information. Aedes aegypti breeds in artificial water containers and feeds during daylight hours, which ties transmission closely to urban density, household water storage, rainfall, and temperature. Aedes albopictus acts as a secondary vector and tolerates cooler climates, extending the potential range of the virus.

Clinical Course and Severe Dengue

Most infections are mild or asymptomatic. Symptomatic cases typically begin with a febrile phase lasting two to seven days, marked by high fever, pain behind the eyes, severe headache, muscle and joint pain, and rash. A small fraction of patients enter a critical phase as the fever falls, characterized by plasma leakage from capillaries, falling platelet counts, hemorrhage, and circulatory shock. No specific antiviral therapy exists, so clinical management rests on careful fluid replacement guided by hematocrit and platelet monitoring, which makes accurate and timely measurement a central concern rather than a supporting one.

Diagnosis and Surveillance

Laboratory confirmation uses NS1 antigen detection, IgM and IgG serology, and reverse-transcription polymerase chain reaction, each with a different useful window relative to symptom onset. Field settings rely heavily on lateral-flow rapid diagnostic tests, and a growing body of research targets microfluidic and electrochemical biosensor platforms that can perform serotype-specific detection at the point of care. Surveillance systems combine case reporting with entomological indices, satellite-derived measures of precipitation and land surface temperature, and statistical or machine learning models that project case counts weeks ahead of an outbreak peak.

Vector Control and Vaccines

Conventional control depends on larval source reduction and insecticide application, both limited by labor cost and by widespread pyrethroid resistance in Aedes populations. Biological approaches have produced stronger evidence. A cluster-randomized trial in Yogyakarta, Indonesia, reported in the New England Journal of Medicine study of Wolbachia-infected mosquito deployments, found a 77 percent reduction in symptomatic dengue and an 86 percent reduction in hospitalizations in treated areas. On the vaccine side, QDenga is licensed in several countries for defined age groups in high-transmission settings, and additional candidates remain under evaluation.

Applications

Dengue fever research draws on a range of technical disciplines, including:

• Biomedical instrumentation for antigen and nucleic acid diagnostics
• Remote sensing and geographic information systems for vector habitat mapping
• Epidemiological modeling and machine learning for outbreak forecasting
• Genetic and microbial engineering for mosquito population suppression
• Public health informatics for case surveillance and reporting